Zimmer Biomet Holdings Stock Alpha and Beta Analysis
| ZBH Stock | USD 99.74 0.28 0.28% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Zimmer Biomet Holdings. It also helps investors analyze the systematic and unsystematic risks associated with investing in Zimmer Biomet over a specified time horizon. Remember, high Zimmer Biomet's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Zimmer Biomet's market risk premium analysis include:
Beta 0.73 | Alpha 0.13 | Risk 1.4 | Sharpe Ratio 0.0336 | Expected Return 0.047 |
Zimmer Biomet Quarterly Cash And Equivalents |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Zimmer Biomet Analysis, Zimmer Biomet Valuation, Zimmer Biomet Correlation, Zimmer Biomet Hype Analysis, Zimmer Biomet Volatility, Zimmer Biomet Price History and analyze Zimmer Biomet Performance. Zimmer Biomet Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Zimmer Biomet market risk premium is the additional return an investor will receive from holding Zimmer Biomet long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Zimmer Biomet. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Zimmer Biomet's performance over market.| α | 0.13 | β | 0.73 |
Zimmer Biomet expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Zimmer Biomet's Buy-and-hold return. Our buy-and-hold chart shows how Zimmer Biomet performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Zimmer Biomet Market Price Analysis
Market price analysis indicators help investors to evaluate how Zimmer Biomet stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Zimmer Biomet shares will generate the highest return on investment. By understating and applying Zimmer Biomet stock market price indicators, traders can identify Zimmer Biomet position entry and exit signals to maximize returns.
| Price Series Summation | ||
| Price Series Division | ||
| Tanh Of Price Series | ||
| Price Floor Movement | ||
| Plus Directional Indicator | ||
| Rate of change | ||
| Triangular Moving Average | ||
| Simple Moving Average | ||
| Tristar Pattern | ||
| Harami Pattern |
Zimmer Biomet Return and Market Media
The median price of Zimmer Biomet for the period between Wed, Nov 26, 2025 and Tue, Feb 24, 2026 is 90.79 with a coefficient of variation of 3.96. The daily time series for the period is distributed with a sample standard deviation of 3.62, arithmetic mean of 91.31, and mean deviation of 2.94. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Disposition of tradable shares by Lori Winkler of Zimmer Biomet subject to Rule 16b-3 | 11/28/2025 |
2 | Acquisition by Michael Farrell of 415 shares of Zimmer Biomet at 90.33 subject to Rule 16b-3 | 12/31/2025 |
3 | Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2025 Financial Results | 01/15/2026 |
4 | Is Zimmer Biomet Pricing Reflect Long Term Value After Multi Year Share Price Slide | 01/28/2026 |
5 | Acquisition by Kurdikar Devdatt of 1404 shares of Zimmer Biomet subject to Rule 16b-3 | 01/29/2026 |
| Zimmer Biomet dividend paid on 30th of January 2026 | 01/30/2026 |
6 | Zimmer Biomet Featured in sp 500 chart Healthcare Snapshot | 02/09/2026 |
7 | ZBH Q4 Deep Dive U.S. Salesforce Overhaul Drives Guidance Caution Amid Product Momentum | 02/11/2026 |
8 | Sound Shore Management Inc CT Decreases Stake in Zimmer Biomet Holdings, Inc. ZBH | 02/12/2026 |
9 | Acquisition by Kurdikar Devdatt of 810 shares of Zimmer Biomet at 92.54 subject to Rule 16b-3 | 02/13/2026 |
10 | The Top 5 Analyst Questions From Zimmer Biomets Q4 Earnings Call | 02/17/2026 |
11 | Bone Wax Market to Reach 73 Million, Globally, by 2033 at 3.2 percent CAGR Allied Market Research | 02/19/2026 |
About Zimmer Biomet Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Zimmer or other stocks. Alpha measures the amount that position in Zimmer Biomet Holdings has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 | 2025 | 2026 (projected) | Dividend Yield | 0.00791 | 0.009136 | 0.0107 | 0.0151 | Price To Sales Ratio | 3.43 | 2.79 | 2.16 | 2.05 |
Zimmer Biomet Upcoming Company Events
As portrayed in its financial statements, the presentation of Zimmer Biomet's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Zimmer Biomet's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Zimmer Biomet's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Zimmer Biomet. Please utilize our Beneish M Score to check the likelihood of Zimmer Biomet's management manipulating its earnings.
| 8th of February 2024 Upcoming Quarterly Report | View | |
| 7th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 8th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Zimmer Biomet
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Zimmer Biomet Analysis, Zimmer Biomet Valuation, Zimmer Biomet Correlation, Zimmer Biomet Hype Analysis, Zimmer Biomet Volatility, Zimmer Biomet Price History and analyze Zimmer Biomet Performance. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Zimmer Biomet technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.